Compliance Strategy for Small to Midsized Companies

February 22, 2013

 

Published for Pharmaceutical Compliance Monitor

On Feb. 20, 2013, Jim Hoover’s article, “Compliance Strategy for Small to Midsized Companies,” published in the online version of Pharmaceutical Compliance Monitor. In the article, Jim discusses the basic steps that small to mid-sized pharmaceutical companies should take when conducting an internal investigation. He instructs  companies to carefully consider the scope and limits of the investigation, who should conduct the investigation, how to protect the relevant privileges, and the possible outcomes of the investigation, prior to conducting the investigation. By fully considering these factors, Jim suggests that companies will be in a better position to correct any problems identified and determine whether or not self-disclosure is warranted. For the full article, please click here.  





Legal Disclaimer:
No representation is made that the quality of services to be performed is greater than the quality of legal services performed by other lawyers.

Featured Attorneys

send article

TESTIMONIALS

  • “He is quick to respond and practical, and the advice he gives is always to the point."

    -Chambers 2012

  • "...He is very good.”

    -Chambers 2012

  • “Does have a fairly significant commercial real estate group.”

    -Chambers 2012

  • “Lauren is smart, professional in word and manner, and quite intuitive in analyzing situations. She thinks through and researches issues before proposing solutions. One of her best qualities is that of keeping her client(s) focused on the defined goals for settling the problems at hand using her cheerful personality.  It is indeed a pleasure working with Lauren."

    -Claire Johnson

  • “He is an excellent products liability lawyer. He is good in front of a jury, always prepared. He is recognized as an excellent lawyer.”

    -Chambers 2012